Locoregional toxicities after adjuvant radiotherapy with or without concurrent bevacizumab in patients with non-metastatic breast cancer

Category Primary study
JournalCancer Research
Year 2013
This article has no abstract
Epistemonikos ID: a74bddd4bf7a74795b6e1a01609d7b2fe4db461a
First added on: Feb 06, 2025